Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Onco-Innovations Ltd. ( (TSE:ONCO) ) is now available.
Onco-Innovations Limited has appointed Jared Rushton to its Board of Directors, bringing over a decade of experience in public markets and strategic advisory across various sectors. This appointment is expected to enhance the company’s market positioning and operational execution. Additionally, the company has engaged MCS Market Communication Service GmbH for online marketing services, which will run until December 15, 2025, or until the budget is exhausted, aiming to boost its digital presence.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company is dedicated to the prevention and treatment of cancer through pioneering research and innovative solutions, and holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 39,885
Technical Sentiment Signal: Strong Sell
See more insights into ONCO stock on TipRanks’ Stock Analysis page.